| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919638 | Radiotherapy and Oncology | 2011 | 6 Pages |
Abstract
This study demonstrates a dosimetric advantage for patients with seroma when simultaneous integrated boost is used with re-planning halfway through treatment.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tanja Alderliesten, Suzanne den Hollander, Tzu-I Jonathan Yang, Paula H.M. Elkhuizen, Anke M. van Mourik, Coen Hurkmans, Peter Remeijer, Corine van Vliet-Vroegindeweij,